Baxter International (BAX) Change in Accured Expenses (2009 - 2026)

Baxter International (BAX) has reported Change in Accured Expenses for 18 consecutive years, with $29.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 262.5% year-over-year to $29.0 million; the TTM figure through Jun 2026 stood at $230.0 million (up 321.15% YoY), while the FY2025 annual figure was $149.0 million, up 238.64% from the prior year.
• Change in Accured Expenses fell to $29.0 million in Q2 2026 per BAX's latest filing, from $203.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $554.0 million in Q4 2023 and bottomed at -$396.0 million in Q4 2022.
• Historically, Change in Accured Expenses has averaged $31.1 million across 5 years, with a median of $18.5 million in 2025.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses plunged 397.06% — and 2024, when it soared 301.68%.
• Baxter International's Change in Accured Expenses stood at -$396.0 million in 2022, then jumped by 239.9% to $554.0 million in 2023, then sank by 126.71% to -$148.0 million in 2024, then soared by 221.62% to $180.0 million in 2025, then sank by 83.89% to $29.0 million in 2026.
• Business Quant data shows BAX's Change in Accured Expenses at $29.0 million in Q2 2026, $203.0 million in Q1 2026, and $180.0 million in Q4 2025.